liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
2016 European Guideline on the management of non-gonococcal urethritis
School of Social and Community Medicine, University of Bristol, UK.
Bristol Sexual Health Centre, University Hospitals Bristol NHS Foundation Trust, UK.
Linköping University, Department of Clinical and Experimental Medicine, Division of Neuro and Inflammation Science. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Local Health Care Services in West Östergötland, Research & Development Unit in Local Health Care.ORCID iD: 0000-0001-8336-9767
Department of Dermatology, New Cross Hospital, UK..
Show others and affiliations
2016 (English)In: International Journal of STD and AIDS (London), ISSN 0956-4624, E-ISSN 1758-1052, Vol. 27, no 11, p. 928-937Article in journal (Refereed) Published
Abstract [en]

We present the updated International Union against Sexually Transmitted Infections guideline for the management of non-gonococcal urethritis in men. This guideline recommends confirmation of urethritis in symptomatic men before starting treatment. It does not recommend testing asymptomatic men for the presence of urethritis. All men with urethritis should be tested for Chlamydia trachomatis and Neisseria gonorrhoeae and ideally M. genitalium using a NAAT as this is highly likely to improve clinical outcomes. If a NAAT is positive for gonorrhoea, a culture should be performed before treatment. In view of the increasing evidence that azithromycin 1 g may result in the development of antimicrobial resistance in Mycoplasma genitalium azithromycin 1 g is no longer recommended as first line therapy, which should be doxycycline 100 mg bd for 7 days. If azithromycin is to be prescribed an extended of 500 mg, then 250 mg daily for 4 days is to be preferred over 1 g stat. In men with persistent NGU, M. genitalium NAAT testing is recommended if not previously undertaken, as is Trichomonas vaginalis NAAT testing in populations where T. vaginalis is detectable in >2% of symptomatic women.

Place, publisher, year, edition, pages
Sage Publications, 2016. Vol. 27, no 11, p. 928-937
Keywords [en]
Chlamydia (Chlamydia trachomatis); non-gonococcal urethritis
National Category
Dermatology and Venereal Diseases Infectious Medicine
Identifiers
URN: urn:nbn:se:liu:diva-128227DOI: 10.1177/0956462416648585ISI: 000384444000001PubMedID: 27147267OAI: oai:DiVA.org:liu-128227DiVA, id: diva2:930262
Available from: 2016-05-23 Created: 2016-05-23 Last updated: 2017-11-30Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records

Falk, Lars

Search in DiVA

By author/editor
Falk, Lars
By organisation
Division of Neuro and Inflammation ScienceFaculty of Medicine and Health SciencesResearch & Development Unit in Local Health Care
In the same journal
International Journal of STD and AIDS (London)
Dermatology and Venereal DiseasesInfectious Medicine

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 256 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf